Osiris Therapeutics, Inc. , the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technology and Diagnostics Forum on Thursday, November 20, 2014 at 9:00 a.m. ET in New York City. A live webcast of the presentation may be accessed through the Investors page of the Company's website at www.Osiris.com .
http://ift.tt/1qd90Cl
http://ift.tt/1qd90Cl
No comments:
Post a Comment